HOME >> MEDICINE >> NEWS
Antibiotic rifampicin shows promise for fighting Parkinson's disease in lab tests

SANTA CRUZ, CA--Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson's disease. The drug also dissolved existing fibrils in laboratory tests.

The researchers studied the effects of rifampicin in test tube experiments and are currently doing studies with cell cultures and mice to see if the same effects occur in living cells. Although these are just the first steps along the path toward clinical studies in humans, the findings suggest that rifampicin and related compounds might be effective in preventing fibril formation and associated neurological damage in patients with Parkinson's disease, said Anthony Fink, professor of chemistry and biochemistry at UCSC.

"Clearly, more work is needed to determine if this would work therapeutically, but if it does it would probably be most useful as a prophylactic therapy used in the early stages of the disease before there is general neurological damage," Fink said.

The research was carried out by a team of scientists in Fink's lab, including postdoctoral researchers Jie Li, Min Zhu, and Sudha Rajamani and research associate Vladimir Uversky. Li is first author of a paper describing their results in the November issue of the journal Chemistry and Biology, which is mailed and published online on November 29.

Aggregation of the protein known as alpha-synuclein into insoluble fibrils is thought to be a critical step in the development of Parkinson's disease, a progressive movement disorder resulting from the death of nerve cells in the brain that produce the neurotransmitter dopamine. Deposits called Lewy bodies, composed mostly of alpha-synuclein fibrils, appear in affected nerve cells, but the connection between the fibrils and cell death remains controversial, Fink said.

"There are t
'"/>

Contact: Tim Stephens
stephens@ucsc.edu
831-459-4352
University of California - Santa Cruz
29-Nov-2004


Page: 1 2 3

Related medicine news :

1. Antibiotics protect nerves in mice by turning on genes
2. Antibiotics within 4 hours of arrival at hospital better for pneumonia patients
3. Antibiotic provides promise in treatment of spinal cord injuries
4. Antibiotic resistant bacteria frequently transmitted between intensive care patients
5. Antibiotic use on swine farms increases efficiency, profits
6. Antibiotic slows atherosclerosis in people with Chlamydia pneumonia antibodies
7. Antibiotics not always beneficial for childhood ear infections
8. Antibiotic could offer promise for treatment of cystic fibrosis
9. Antibiotics help heart patients
10. Antibiotic prescription patterns violate guidelines, increase costs
11. Antibiotic prescribing in local communities is linked to localised resistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... ... September 17, 2019 , ... Since the registration ... Century Cures Act in the US, Nocimed has been marketing its unique technology ... images from existing MRI equipment to perform MR spectroscopy, NociScan detects the presence ...
(Date:9/17/2019)... Village, CA (PRWEB) , ... September 17, 2019 ... ... in Westlake Village, CA, incision-free treatment with laser dentistry . A minimally ... to perform than traditional osseous surgery. , Laser dentistry is gentle and ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... largest accountable care organization (ACO) in the country, the company announced today. High-performing ... to improve care quality and increase cost efficiency. This opportunity is open to ...
(Date:9/17/2019)... ... , ... Lubin Austermuehle, P.C. will be one of the sponsors ... held at Found Kitchen and Social House in Evanston on Monday, October 7 from ... Disorder, a rare condition that results from changes to the GRIN2B gene. The GRIN2B ...
(Date:9/17/2019)... ... September 17, 2019 , ... Specialty Technical Publishers (STP) ... Audit Protocol Consortium (IAPC) EHS audit protocol for Japan . Leading companies ... their EHS regulatory obligations and rapidly collect, share, archive, and export audit findings ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Today, in partnership with ... contraception and consent with student and faculty from The City University of New ... Francisco Ramirez, MPH; Elise Schuster, MPH; Raffaele M. Bernardo, DO, FACP, AAHIVS and ...
(Date:9/17/2019)... ... September 17, 2019 , ... Embr Labs , the ... Series B funding led by DigiTx Partners, with participation from Safar Partners, ... use the investment to grow the company’s footprint in wellness and digital therapeutics, accelerate ...
(Date:9/17/2019)... ... September 17, 2019 , ... Gustavo Grodnitzky, PhD will join the ... Yoga Science as holistic mind/body medicine for physicians and other health care professionals. Entitled ... 22-26, 2019 at the Cranwell Resort and Spa in Lenox, Massachusetts, is accredited by ...
Breaking Medicine Technology:
Cached News: